Unknown

Dataset Information

0

MK2 is a therapeutic target for high-risk multiple myeloma.

ABSTRACT:

SUBMITTER: Gu C 

PROVIDER: S-EPMC8168486 | biostudies-literature |

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown FOXM1 is a therapeutic target for high-risk multiple myeloma.
| S-EPMC4826574 | biostudies-literature
Unknown DPP8 is a novel therapeutic target for multiple myeloma.
| S-EPMC6889119 | biostudies-literature
Unknown PHF19 inhibition as a therapeutic target in multiple myeloma.
| S-EPMC8316274 | biostudies-literature
Unknown PLP2 Expression as a Prognostic and Therapeutic Indicator in High-Risk Multiple Myeloma.
| S-EPMC7303762 | biostudies-literature
Unknown PI3K/p110{delta} is a novel therapeutic target in multiple myeloma.
| S-EPMC2938837 | biostudies-other
Unknown PDK1 inhibition is a novel therapeutic target in multiple myeloma.
| S-EPMC3553526 | biostudies-literature
Unknown HLA-E Binding Peptide as a Potential Therapeutic Candidate for High-Risk Multiple Myeloma.
| S-EPMC8219970 | biostudies-literature
Unknown Targeting MK2 Is a Novel Approach to Interfere in Multiple Myeloma.
| S-EPMC6694709 | biostudies-literature
Unknown Histone deacetylase 3 as a novel therapeutic target in multiple myeloma.
| S-EPMC4165599 | biostudies-literature
Unknown Kinome expression profiling to target new therapeutic avenues in multiple myeloma.
| S-EPMC7049359 | biostudies-literature